Splice-switching of the insulin receptor pre-mRNA alleviates tumorigenic hallmarks in rhabdomyosarcoma
Abstract Rhabdomyosarcoma (RMS) is an aggressive pediatric tumor with a poor prognosis for metastasis and recurrent disease. Large-scale sequencing endeavors demonstrate that Rhabdomyosarcomas have a dearth of precisely targetable driver mutations. However, IGF-2 signaling is known to be grossly alt...
Main Authors: | Safiya Khurshid, Matias Montes, Daniel F. Comiskey, Brianne Shane, Eleftheria Matsa, Francesca Jung, Chelsea Brown, Hemant Kumar Bid, Ruoning Wang, Peter J. Houghton, Ryan Roberts, Frank Rigo, Dawn Chandler |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-01-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-021-00245-5 |
Similar Items
-
Tumorigenic de-differentiation: the alternative splicing way
by: Debleena Ray, et al.
Published: (2020-11-01) -
Regulation of tumorigenic splicing by protein condensates with specific biophysical properties
by: Wei Li, et al.
Published: (2020-11-01) -
Loss of Endocan tumorigenic properties after alternative splicing of exon 2
by: Scherpereel Arnaud, et al.
Published: (2008-01-01) -
Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine
by: Mohammad Alinoor Rahman, et al.
Published: (2020-05-01) -
Rhabdomyosarcoma
by: Chaudhuri P, et al.
Published: (1980-01-01)